IDEAS home Printed from https://ideas.repec.org/a/spr/scient/v91y2012i1d10.1007_s11192-011-0556-x.html
   My bibliography  Save this article

Top journals selectivity index and “me-too” drugs

Author

Listed:
  • Igor Kissin

    (Harvard Medical School
    Brigham and Women’s Hospital)

  • Edwin L. Bradley

    (University of Alabama)

Abstract

To assess the probability of success of an analgesic drug we have proposed a bibliometric indicator, the Top Journals Selectivity Index (TJSI) (Kissin 2011). It represents the ratio (as %) between the number of all types of articles on a particular drug in the top 20 biomedical journals and the number of articles on that drug in all (>5,000) journals covered by Medline over the first 5 years after that drug’s introduction. The aim of this study was to demonstrate that TJSI may be used for the assessment of follow-on drugs (those that follow a first-in-class drug). The study tested two hypotheses. First, TJSI can detect the difference (in the same class) between drugs with distinguishing features and drugs without them (“me-too” drugs) better than other publication indices, i.e., the number of all types of articles on a drug in journals presented by Medline (AJI), and the number of articles covering only randomized controlled trials (RCT). Second, there is a relationship between the TJSI of “me-too” drugs and the order (sequential number) in which those drugs reached the market. The study was based on drug classes approved for marketing between the 1960’s and the early 2000’s. The eight classes that had 4 or more drugs were included for analysis. Five specific indicators were used to determine drug’s distinguishing pharmacological properties. It was found that TJSI can detect the difference between follow-on drugs with distinguishing features and those without them better than the other publication indices (AJI or RCT). Our analysis also demonstrated a negative correlation (r = −0.372, p = 0.014) between the TJSI of drugs without distinguishing features (“me-too” drugs) and the order of the drug’s market entry. This implies that TJSI could be useful for the assessment of situations with multiple market entrants in the same class when a new addition has a questionable value.

Suggested Citation

  • Igor Kissin & Edwin L. Bradley, 2012. "Top journals selectivity index and “me-too” drugs," Scientometrics, Springer;Akadémiai Kiadó, vol. 91(1), pages 131-142, April.
    • Handle: RePEc:spr:scient:v:91:y:2012:i:1:d:10.1007_s11192-011-0556-x
    DOI: 10.1007/s11192-011-0556-x
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s11192-011-0556-x
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s11192-011-0556-x?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Igor Kissin & Edwin L. Bradley, 2011. "Top Journals Selectivity Index: is it acceptable for drugs beyond the field of analgesia?," Scientometrics, Springer;Akadémiai Kiadó, vol. 88(2), pages 589-597, August.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Li, Xin & Tang, Xuli, 2021. "Characterizing interdisciplinarity in drug research: A translational science perspective," Journal of Informetrics, Elsevier, vol. 15(4).

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Ricardo Arencibia-Jorge & Elena Corera-Alvarez & Zaida Chinchilla-Rodríguez & Félix Moya-Anegón, 2016. "Scientific output of the emerging Cuban biopharmaceutical industry: a scientometric approach," Scientometrics, Springer;Akadémiai Kiadó, vol. 108(3), pages 1621-1636, September.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:scient:v:91:y:2012:i:1:d:10.1007_s11192-011-0556-x. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.